Literature DB >> 31079326

miR-376a inhibits the proliferation and invasion of osteosarcoma by targeting FBXO11.

Qiaolong Xu1, Li Cheng1, Jianyang Chen2, Wenjie Lu1, Peinian Wang1.   

Abstract

Dysregulation of microRNAs (miRNAs) is frequently found in the tumorigenesis of osteosarcoma (OS). miR-376a was found to play tumor suppressive roles in human cancers. However, the role of miR-376a in OS remains unclear. The expression of miR-376a was analyzed by quantitative real-time PCR (qRT-PCR) in OS cell lines. Cell proliferation assay, cell invasion assay, and cell apoptosis assay were performed to detect the biological function of miR-376a after synthetic miRNA transfection. The target of miR-376a was predicted by TargetScan and miRDB, and further validated by luciferase activity reporter assay and western blot. miR-376a expression was revealed to be decreased in OS cell lines. In vitro experiments showed that overexpression of miR-376a inhibits OS cell proliferation and invasion but promotes apoptosis. Luciferase activity reporter assay and western blot assay showed F-box protein 11 (FBXO11) was a direct target of miR-376a. Furthermore, FBXO11 mediated the role of miR-376a on the proliferation, invasion, and apoptosis of OS cells. Collectively, these results revealed miR-376a functions as a tumor suppressor by targeting FBXO11 in OS. It may be developed as a therapeutic target for OS patients.

Entities:  

Keywords:  FBXO11; Osteosarcoma; Tumor suppressive miRNA; miR-376a

Mesh:

Substances:

Year:  2019        PMID: 31079326     DOI: 10.1007/s13577-019-00256-2

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  18 in total

Review 1.  MicroRNAs with a role in gene regulation and in human diseases.

Authors:  Sami Ullah; Peter John; Attya Bhatti
Journal:  Mol Biol Rep       Date:  2013-11-06       Impact factor: 2.316

Review 2.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

3.  FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.

Authors:  Uk-Il Ju; Jong-Wan Park; Hyoung-Sook Park; Sang Jeong Kim; Yang-Sook Chun
Journal:  Biochem Biophys Res Commun       Date:  2015-07-14       Impact factor: 3.575

Review 4.  OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.

Authors:  Alexander A Svoronos; Donald M Engelman; Frank J Slack
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

5.  Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.

Authors:  Cheng Zhang; Yu Liang; Ming-Hui Ma; Kun-Zhe Wu; Chun-Dong Zhang; Dong-Qiu Dai
Journal:  Cell Physiol Biochem       Date:  2018-12-06

6.  MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc.

Authors:  Youyu Wang; Wei Cong; Gang Wu; Xueming Ju; Zhixi Li; Xin Duan; Xueli Wang; Hong Gao
Journal:  Cell Biol Int       Date:  2017-09-11       Impact factor: 3.612

Review 7.  New targets and approaches in osteosarcoma.

Authors:  Jonathan Gill; Manpreet K Ahluwalia; David Geller; Richard Gorlick
Journal:  Pharmacol Ther       Date:  2012-09-14       Impact factor: 12.310

Review 8.  Advances in targeted therapy for osteosarcoma.

Authors:  Wenya Zhou; Mengze Hao; Xiaoling Du; Kexin Chen; Guowen Wang; Jilong Yang
Journal:  Discov Med       Date:  2014-06       Impact factor: 2.970

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  MicroRNA‑376a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1.

Authors:  Yuefeng Li; Yunxia Wu; Zhigang Sun; Ruiyu Wang; Deliang Ma
Journal:  Mol Med Rep       Date:  2017-11-15       Impact factor: 2.952

View more
  7 in total

1.  Ultrasound-targeted microbubble destruction-mediated silencing of FBXO11 suppresses development of pancreatic cancer.

Authors:  Jing Xue; Shengjiang Chen; Dongfeng Ge; Xiaozhi Yuan
Journal:  Hum Cell       Date:  2022-04-18       Impact factor: 4.174

2.  MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway.

Authors:  Qian Liang; Huan Zhang
Journal:  Cancer Biol Ther       Date:  2020-12-07       Impact factor: 4.742

3.  LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p.

Authors:  Longde Shen; Yinyin Wu; Ailu Li; Lichun Li; Longyuan Shen; Qiuxia Jiang; Qiuxia Li; Zhifen Wu; Liji Yu; Xiaohong Zhang
Journal:  Oncol Rep       Date:  2020-07-15       Impact factor: 3.906

4.  miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2.

Authors:  Jiekun Guo; Qiang Wu; Xiaoming Peng; Bin Yu
Journal:  Biomed Res Int       Date:  2019-12-16       Impact factor: 3.411

5.  Tumor Suppressor Function of miR-127-3p and miR-376a-3p in Osteosarcoma Cells.

Authors:  Joerg Fellenberg; Burkhard Lehner; Heiner Saehr; Astrid Schenker; Pierre Kunz
Journal:  Cancers (Basel)       Date:  2019-12-14       Impact factor: 6.639

6.  Allicin Inhibits Osteosarcoma Growth by Promoting Oxidative Stress and Autophagy via the Inactivation of the lncRNA MALAT1-miR-376a-Wnt/β-Catenin Signaling Pathway.

Authors:  Wenpeng Xie; Wenjie Chang; Xiaole Wang; Fei Liu; Xu Wang; Daotong Yuan; Yongkui Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-06-24       Impact factor: 7.310

7.  Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1.

Authors:  Shenglong Li; Fei Liu; Yi Pei; Wei Wang; Ke Zheng; Xiaojing Zhang
Journal:  Aging (Albany NY)       Date:  2019-09-16       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.